Number of the records: 1
Compounds for treatment of senescence-related disorders
- 1.
SYSNO ASEP 0557195 Document Type P - Patent R&D Document Type Patent or other outcome protected by special legislation Title Compounds for treatment of senescence-related disorders Author(s) Hubáčková, Soňa (BTO-N)
Werner, Lukáš (BTO-N)
Štursa, Jan (BTO-N)
Neužil, Jiří (BTO-N) RIDNumber of authors 4 Year of issue 2018 Possible third party use of the result A - Pro využití výsledku jiným subjektem je vždy nutné nabytí licence Royalty requested A - Poskytovatel licence požaduje licenční poplatek Patent no. or utility model no. or industrial design no. AU2017368107 Date of the patent acceptance 07.06.2018 Name of the patent owner Springtide Ventures s.r.o., Smart Brain s.r.o., Biotechnologicky ustav AV CR, v. v. i., MitoTAX s.r.o. Code of the issuer name AU001 - IP Australia Phillip ACT Current use A - Pouze udělený (dosud nevyužívaný) patent nebo patent využívaný jeho vlastníkem Language eng - English Keywords Senescence ; Mitochondria ; Longevity Subject RIV EB - Genetics ; Molecular Biology OECD category Biochemistry and molecular biology Institutional support BTO-N - RVO:86652036 Annotation The present invention relates to compounds of general formula (I) in particular for use in the treatment of senescence-related diseases, such as idiopathic pulmonary fibrosis, sarcopenia, diabetes, obesity, osteoarthritis, chronic inflammations, glaucoma, cataracts, radiation-induced oral mucosis, renal transplantation, prostatic hyperplasia. Workplace Institute of Biotechnology Contact Monika Kopřivová, Monika.Koprivova@ibt.cas.cz, Tel.: 325 873 700 Year of Publishing 2022 Electronic address https://worldwide.espacenet.com/patent/search/family/057471690/publication/AU2017368107B2?q=pn%3DAU2017368107B2
Number of the records: 1